Apr 14, 2020 / 05:30PM GMT
Serge Belanger - Needham & Company - Analyst
Hi, good afternoon. I am Serge Belanger, one of the healthcare analysts at Needham. Thanks for dialing in or logging in to the 19th Annual Needham Conference. For our next session we have Collegium Pharmaceuticals. Paul Brannelly, the CFO, as well as Joe Ciaffoni, the CEO, are both with us to talk about Collegium. Gentlemen?
Paul Brannelly - Collegium Pharmaceutical, Inc. - EVP & CFO
Great, thanks, Serge. Before we begin today's fireside chat we want to remind everyone that none of the information presented today is intended to be promotional and that any forward-looking statements made today are made pursuant to the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995.
You are cautioned that such forward-looking statements involve risks and uncertainties including and without limitation the risks that we may incur significant expense and may not prevail in current or future opioid industry litigation and investigations or other litigations pertaining to our products. These
Collegium Pharmaceutical Inc at Needham Healthcare Conference Transcript
Apr 14, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers